Trial Profile
Bioavailability and tolerability study of two new DHEP-medicated plasters in comparison with the marketed DHEP-medicated plaster 1.3% (Flector®): a single-centre, multiple-dose, randomised, three-way cross-over, open-label, bioavailability and tolerability study
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Jan 2017
Price :
$35
*
At a glance
- Drugs Diclofenac hydroxyethylpyrrolidine (Primary)
- Indications Pain
- Focus Pharmacokinetics
- Sponsors IBSA
- 23 Jan 2017 New trial record